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Abstract
Objective-To study insulin dependent diabetic patients for change in non-proliferative retinopathy and its relation to glycaemic control and to various clinical background data.
Design-Prospective study with follow up for seven years.
Setting-Outpatient departments of university hospitals.
Main outcome measures-Glycated haemoglobin concentration; degree of retinopathy.
Results-Retinopathy worsened by an overall increase in counts of microaneurysms and haemorrhages from 17 (SD 25) to 45 (58) (p=0 005). Intensified insulin treatment and home blood glucose monitoring improved concentrations of glycated haemoglobin (HbA1) from 11-2% (2.2%) at the start of the study to a mean of 9-5% (1-5%) over the seven years of the study (p<0-0001). A mean value for HbAl >10% was associated with an increased risk of progression of retinopathy and a mean value <8-7% was associated with a diminished risk. Multiple regression analysis identified four independent variables as indicative of outcome of retinopathy after seven years: HbAl value at baseline; the change in HbAl from start to the mean 
Introduction
An accumulation of data suggests an association between hyperglycaemia and the incidence and progression of diabetic retinopathy. '9 Intervention studies, in which attempts have been made to lower mean blood glucose levels give conflicting results regarding beneficial effects on progression of retinopathy'620-but they have all studied the patients for only a short period, up to three years.
The severity of retinopathy is related mainly to the duration of diabetes. Exposure to various factors in diabetes can be characterised by intensity, duration, and cumulative dose (intensity times duration).2' The results obtained in a well designed study may depend on a cumulative dose being reached through sufficient duration of the study. This is illustrated by our study, in which the same patients were examined by identical tests at intervals for seven years.
The Oslo study was originally designed as a prospective, randomised study of the effects of insulin pumps, multiple insulin injections, and conventional treatment with insulin.22-27 Results after two years showed marginal beneficial effect ofintervention on progression of retinopathy.25 This effect was not evident after three to four years,26 even though assessment was performed according to both the mode of insulin treatment and the mean blood glucose concentration. After seven years' follow up, however, the long term beneficial effects of improved glycaemic control were evident.
The present paper determines the change in retinopathy after seven years, examines relevant clinical variables, identifies four independent risk factors, and presents a long term regression model for severity of non-proliferative retinopathy.
Patients and methods
Forty five insulin dependent diabetic patients were included in the Oslo study seven years ago. Inclusion criteria and background clinical data have been described previously.2227 Table I shows background data relevant to the current paper at the start of the study and after seven years. At baseline, the 21 men and 24 women averaged 26 (range 18-36) years and had had diabetes for 13 (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) Throughout the study each of the 45 patients had had a total of 11 eye examinations at intervals of no more than one year. Fundus colour photography was performed, and retinopathy was assessed by a masked counting of microaneurysms and haemorrhages ("red spots"). The individual retinopathy score was obtained by the counts from a 300 standard field photograph of both eyes. Details of variability and concordance are described elsewhere. 26 Transient proliferative retinopathy developed in a 22 year old woman after six months29 and in a 23 year old woman after six years. As spontaneous regression occurred photocoagulation treatment was not performed. In a 30 year old man fibrovascular proliferative retinopathy (mean concentration of glycated haemoglobin (HbA1) over seven years 13 5%) was detected at the seven year eye examination. He received laser treatment after completing the protocol.
Blood pressure (mm Hg) was measured at the time of the eye examination by auscultation after five minutes' rest in the seated position. Microalbuminuria was determined by immunoturbidometry in a 24 hour urine collection (mg/24 h) within two months of the eye examination.
A two tailed Wilcoxon signed rank test was used to compare values at baseline and after seven years.
Correlation was performed by Spearman's method. Multivariate regression analysis was used for identifying independent variables for development of retinopathy. As all variables except microaneurysms and haemorrhages had a nearly normal distribution, in the multivariate analysis we used parametric statistics after logarithmic transformation of microaneurysms and haemorrhages. Parametric statistics were used in this analysis as appropriate non-parametric multivariate methods were not available. The level of significance was 5%.
Results
Clinical data at the start of the study and after seven years' follow up are presented in tables I and II. In the 45 patients systolic blood pressure rose significantly (p=0 002), overall retinopathy worsened (p=0 005), and, of course, age and duration of diabetes increased by seven years. One patient received antihypertensive drugs during the last four years of the study. Details of changes in urinary albumin excretion rate (table I) will be described elsewhere.
The mean concentration of HbAl was significantly reduced in participants in the study: 11 2% (SD 2 2%); range 7-5-18 9%) at the start, compared with 9 5% (1 5%; 7-3-13 2%) after seven years, a change of 1 7% (2 0%; -3 1-7-1%, p<0-0001). The concentration did not drift upwards when, after 41 months of strict randomisation,26 treatment was allocated according to patients' preference. The differences in glycaemic control between the three modes of insulin treatment during the first 41 months seem to have been sustained through the rest of the study. The seven year mean HbAI concentrations, according to the original randomisation ("intension to treat") were 9-1% (1 1%) in the group treated by insulin pump; 9-3% (1-4%) in the group treated by multiple injections; and 10-4% (1-5%) in the group given conventional insulin treatment. The mean HbAI values during the months preceding the eye examination at 41 months were 9 -1%, 9-3%, and 10-5% respectively. BMJ VOLUME 304 Clinical background data (table I) were tested for possible relations to retinopathy at baseline and at seven years and for the ability to predict degree of retinopathy at seven years (table IV). The duration of diabetes was correlated with the severity of retinopathy at baseline (p=0 01) and at seven years (p=0 04) and was a predictive risk factor for retinopathy after seven years (p=002). The severity of retinopathy was not correlated to age, blood pressure, or kidney function, and patients with the most retinopathy at baseline were more likely to have more severe retinopathy seven years later (r=0-41; p=O005) (data not shown). Table V shows four independent variables related to severity of retinopathy at seven years. Retinopathy was not correlated to the baseline HbA1 value (r=0-22; p=0 14; data not shown). Given the notion that HbAI concentration at baseline could be indicative of glycaemic control in the preceding years of diabetes, this value was included in a multiple regression analysis. Further, the fact that significant improvement in glucose control was obtained for a period of seven years, as compared with HbA1 concentration at baseline, initiated an analysis of individual changes of HbAl from baseline to the mean value through seven years. The HbA1 value at baseline, the change in HbAl concentration, the duration of diabetes, and the retinopathy at baseline were all independent variables.
To evaluate the relative influence of these four variables on severity of retinopathy after seven years
Discussion
The most important finding of the present study is that long term lowering of blood glucose concentration retards the progression of diabetic retinopathy. Secondary glycaemic intervention has a beneficial effect on established retinopathy, even in subjects who have had diabetes for up to 23 years. This study also indicates that hyperglycaemia plays an important part in the pathogenesis of diabetic retinopathy.
Relations between blood glucose concentration and retinopathy were assessed by three separate methods: the predictive value of the baseline concentration of glycated haemoglobin, the impact of treatment over seven years, and the grouping of subjects according to mean HbAl concentration over the seven years. The
HbA, value at inclusion may, in a sense, represent glycaemic control during the preceding years. The multiple regression analysis gives support to this assumption: patients with higher HbAl values at inclusion had greater retinopathy seven years later. This agrees with the four year results of the Wisconsin epidemiological study, in which the progression of retinopathy was associated with a single measurement of glycated haemoglobin.5 In the present study the "predictive" impact of the HbAl concentration at inclusion was statistically detectable, in spite of intervention, as improved glycaemic control through the next seven years. This reflects the long term relation between glycaemic control and retinopathy and explains, in part, the difficulty in finding this relation in previous studies. 12-19 22 23 25 26 Because it has been claimed that inherent characteristics determine both HbAl concentration and the development of diabetic retinopathy we studied the metabolic intervention in each subject as individual changes from the baseline value to the mean vaue for HbA1 over seven years. The overall glycaemic control improved from an average HbAl concentration of above 10% were associated with a significantly increased risk of progression to severe non-proliferative retinopathy, although no obvious increment was found at this level. The number of microaneurysms and haemorrhages at baseline was an independent risk factor for more severe retinopathy seven years later. This accords with a population based study in Wisconsin which found that the microaneurysm count at baseline predicted the four year progression of retinopathy.80 This long term prediction was independent of the starting level of glycated haemoglobin, as in the present study; we also found that it was independent of seven years' improvement in glycaemic control. Short term effects may, however, be different. Kohner Neither age, blood pressure, nor urinary albumin excretion were correlated with retinopathy at baseline or at seven years. These variables had no predictive ability in selecting patients at high risk of severe retinopathy seven years later.
The role of blood glucose in the incidence and progression of retinopathy is pathogenetically complex. The present study shows that long term improved control retards progression of retinopathy after seven years, but short term rapid lowering of blood glucose concentrations may transiently worsen retinopathy,'3422233 2 affecting the severity of retinopathy for at least a year.28 This emphasises the critical need for closely monitoring both retinopathy and blood glucose; single cross sectional associations may be misleading. Furthermore, the course of the disease before patients entered the study may have had a considerable impact on the end results. This has previously been shown by Engerman and Kern: good glycaemic control from the start of diabetes inhibited development of retinopathy in dogs but was less efficient in inhibiting retinopathy if good control had been preceded by a long period of poor control. 3 The present study has identified clinical variables that characterise the severity of retinopathy after secondary intervention by intensified insulin treatment. Four risk factor can be applied to individual patients to calculate the probability of increased severity of retinopathy. A risk index for retinopathy has been derived by modelling the intensity, duration, and cumulative dose of each factor, and the informative value of the model should be superior to the clinical use of a single risk factor such as duration of diabetes. The practical value of the present model has to be tested in future studies on different populations of diabetic patients.
